Radiotherapy may work synergistically with immunotherapy, preclinical evidences indicated that radiotherapy may re-programme tumor microenvironment by promoting the release of tumor neoantigen, activating innate immune response via cGAS/STING pathway and improve immune cell infiltration. The gene discussed is STING1; the disease is neoplasm.